Ragosa Mark (CIK 1835458) reported 54 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-03). Recent activity: Buy KNSA (2,694 shares), Buy KNSA (1,750 shares), Buy KNSA (1,591 shares), Buy KNSA (3,069 shares), Sell KNSA (4,404 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Buy | 2,694 | $0 |
| 2026-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Buy | 1,750 | $0 |
| 2026-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Buy | 1,591 | $0 |
| 2026-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Buy | 3,069 | $0 |
| 2026-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Sell | 4,404 | $349,149 |
| 2026-04-08 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Buy | 2,694 | $0 |
| 2026-04-08 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Sell | 1,303 | $63,769 |
| 2026-04-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Buy | 5,187 | $0 |
| 2026-04-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Sell | 2,510 | $120,806 |
| 2026-03-11 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Sell | 17,981 | $819,574 |
| 2026-03-11 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Buy | 10,513 | $186,711 |
| 2026-03-11 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Buy | 13,813 | $249,463 |
| 2026-03-11 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Buy | 10,360 | $277,026 |
| 2026-03-11 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Buy | 2,036 | $46,604 |
| 2026-03-11 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Sell | 18,741 | $866,584 |
| 2026-02-11 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Buy | 8,374 | $108,611 |
| 2026-02-11 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Buy | 2,471 | $41,760 |
| 2026-02-11 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Sell | 9,114 | $390,535 |
| 2026-02-11 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Sell | 8,731 | $381,719 |
| 2026-01-09 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Sell | 12,000 | $502,680 |
| 2025-12-10 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Buy | 16,164 | $179,420 |
| 2025-12-10 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Buy | 16,165 | $193,495 |
| 2025-12-10 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Buy | 10,512 | $113,109 |
| 2025-12-10 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Sell | 42,841 | $1.8M |
| 2025-11-14 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | Buy | 19,900 | $615,507 |
来源：SEC Form 4 申报文件 · 截至 2026-09-03